Many cancer drugs remain unproven 5 years after accelerated approval, says Study
The promise of early access to potentially life-saving drugs through the US Food and Drug Administration’s accelerated approval program often comes with high hopes for patients battling debilitating or fatal diseases. However, a recent study sheds light on the reality that many of these drugs fail to demonstrate significant benefits within a reasonable timeframe. Dr. […]